Kadmon Holdings Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kadmon Holdings Inc with three other
companies in this sector in the United States:
Syndax Pharmaceuticals Inc
sales of $1.52 million
of which 100%
Emmaus Life Sciences Inc
Onconova Therapeutics Inc
Sales fell dramatically in 2018:
Kadmon Holdings Inc reported sales of $1.40 million
December of 2018.
decrease of 88.6%
versus 2017, when the company's sales were $12.26 million.